Fundraising Fox

Joanna Wolak

Executive at EndLyz Therapeutics

London, England, United Kingdom

Find your path to Joanna

20 people in our graph share verified history with Joanna — schools, employers, funds. One of them is your warm intro.

Damian CrowtherunlockedJoanna: together at Dementia Discovery (2022)
×9Joanna: together at Dementia Discovery
×2Joanna: together at EndLyz Therapeutics

Executive at EndLyz Therapeutics

Intro paths

→

In turn, Joanna can intro founders to EndLyz Therapeutics's investors below.

EndLyz Therapeutics's investors · 2

Dementia Discovery FundLondonOxford Science EnterprisesOxford · $63.5K – $31.8M checks

Experience

  1. Endlyz TherapeuticsChief Executive Officercurrent2025 — presentLondon Area, United Kingdom
  2. Endlyz TherapeuticsPresident & Chief Scientific Officer2021 — 2025Greater London, England, United Kingdom
  3. The Dementia Discovery FundVenture Partner2021 — 2022
  4. The Dementia Discovery FundSenior Advisor2020 — 2021
  5. AviadoBioBoard Member2020 — 2021United Kingdom
  6. Eli Lilly and CompanyNeuroinflammation Group Leader2019 — 2020
  7. Eli Lilly and CompanyPrincipal Research Scientist & Team Leader2017 — 2020
  8. Eli Lilly and CompanySenior Research Scientist & Team Leader2012 — 2017
  9. Structural Enzymology and Biochemistry Laboratory, CNRS, Gif-sur-Yvette, FrancePostdoctoral Research Assistant – Research Fellow2004 — 2007

Skills & more

Drug DiscoveryNeuroscience

Languages English

From Joanna's professional profile.

Frequently asked questions

Who is Joanna Wolak?
Executive Officer, Director at EndLyz Therapeutics
Where does Joanna Wolak work?
Joanna Wolak is Executive at EndLyz Therapeutics.
Where did Joanna Wolak go to school?
Joanna Wolak studied at Dept. of Molecular and Cellular Biology, Faculty of Biotechnology, University of Gdansk, Poland (Ph.D., Biochemistry); Dept. of Biochemistry, University of Gdansk, Poland (M.Sc., Molecular Biology).

Shared employers

Also worked at Endlyz Therapeutics3

Damian Crowtherex-AstraZeneca at PICUS CAPITALCraig FoxOperating Partner, Life Sciences at Oxford Science EnterprisesDonmienne LeungDirector II, Head of AbbVie Ventures Europe at AbbVie

Also worked at The Dementia Discovery Fund6

Damian Crowtherex-AstraZeneca at PICUS CAPITALChristian JungPartner at Dementia DiscoveryMiles GersonPartner at Dementia Discovery FundJonathan BehrPartner at SV Health InvestorsDirk LandgrafPrincipal at SV Health InvestorsCaroline BennCo-founder & CSO at LoQus23

Also worked at AviadoBio12

Dominic SchmidtGeneral Partner at Advent Life SciencesMartin TaylorPrincipal at F-Prime Capital PartnersNihal SinhaPartner at F-Prime Capital PartnersJeff GoaterPartner at The Column GroupTim FunnellPartner at Monograph Capital PartnersPhilip ScheltensHead of EQT Dementia Fund at EQT Life Sciences

+ 6 more

Also worked at Eli Lilly and Company187

David MollerInvestor at Third Rock VenturesJesper GromadaInvestor at Third Rock VenturesMark LevinRetired Founding Partner at Third Rock VenturesNatalie FurneyGlobal General Counsel at Takeda VenturesRhonda PachecoPresident, U.S. Business Unit and U.S. Country Head at Takeda VenturesCarlos PayaVenture Partner at Ysios Capital

+ 181 more